Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings

By Zucker K.   Rosen A.   Tsaroucha A.   de Faria L.   Roth D.   Ciancio G.   Esquenazi V.   Burke G.   Tzakis A.   Miller J.  

Transplant Immunology, Vol. 5, Iss. 3, 1997-09 ,pp. : 225-232

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patients

By Aigrain E.J.   Shaghaghi E.K.   Baudouin V.   Popon M.   Loirat C.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 388-390

Elsevier

Access to resources Recommend Favorite

Decreased Rejection Episodes in African-American Renal Transplant Recipients Receiving Mycophenolate Mofetil/Tacrolimus Therapy

By Weber M.   Deng S.   Arenas J.   Aradhye S.   Grossman R.   Shaw L.   Naji A.   Barker C.   Brayman K.L.  

Transplantation Proceedings, Vol. 29, Iss. 8, 1997-12 ,pp. : 3669-3670

Elsevier

Access to resources Recommend Favorite

Mycophenolate Mofetil (Cellcept) in Renal Transplantation: The European Experience

By European Mycophenolate Mofetil Co-operative Study Group   Garl S.   Wiesel M.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2932-2935

Elsevier

Access to resources Recommend Favorite

Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and cellcept combination therapy

By Tsaroucha A.K.   Zucker K.   Esquenazi V.   de Faria L.   Miller J.   Tzakis A.G.  

Transplant Immunology, Vol. 8, Iss. 2, 2000-06 ,pp. : 143-146

Elsevier

Access to resources Recommend Favorite